{
    "id": 29090,
    "fullName": "POLE P286R",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "POLE P286R lies within the exonuclease domain of the Pole protein (PMID: 29352080). P286R is associated with hypermutation in patient samples (PMID: 27612425, PMID: 23528559), results in a perturbation of the DNA-binding pocket by structural modeling (PMID: 23528559), and confers impaired exonuclease activity and increased mutation rate compared to wild-type Pole in vitro (PMID: 25228659, PMID: 29352080).",
            "references": [
                {
                    "id": 13196,
                    "pubMedId": 27612425,
                    "title": "The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27612425"
                },
                {
                    "id": 6258,
                    "pubMedId": 25228659,
                    "title": "Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25228659"
                },
                {
                    "id": 13143,
                    "pubMedId": 29352080,
                    "title": "Functional Analysis of Cancer-Associated DNA Polymerase \u03b5 Variants in Saccharomyces cerevisiae.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29352080"
                },
                {
                    "id": 7232,
                    "pubMedId": 23528559,
                    "title": "DNA polymerase \u03b5 and \u03b4 exonuclease domain mutations in endometrial cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23528559"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5426,
        "geneSymbol": "POLE",
        "terms": [
            "POLE",
            "CRCS12",
            "FILS",
            "IMAGEI",
            "POLE1"
        ]
    },
    "variant": "P286R",
    "createDate": "12/10/2018",
    "updateDate": "01/08/2019",
    "referenceTranscriptCoordinates": {
        "id": 177877,
        "transcript": "NM_006231",
        "gDna": "chr12:g.132676598G>C",
        "cDna": "c.857C>G",
        "protein": "p.P286R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16102,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with refractory uterine carcinosarcoma who was found to have high tumor mutational burden and two mutations in POLE, P286R and T323A, on a biopsy from progression achieved a partial response to treatment with Keytruda (pembrolizumab) that was ongoing at 12 months (PMID: 29386312).",
            "molecularProfile": {
                "id": 31505,
                "profileName": "POLE P286R POLE T323A TMB high"
            },
            "therapy": {
                "id": 1447,
                "therapyName": "Pembrolizumab",
                "synonyms": null
            },
            "indication": {
                "id": 6171,
                "name": "uterine carcinosarcoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14263,
                    "pubMedId": 29386312,
                    "title": "Tumor Mutational Burden Guides Therapy in a Treatment Refractory POLE-Mutant Uterine Carcinosarcoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29386312"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31049,
            "profileName": "POLE P286R",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31505,
            "profileName": "POLE P286R POLE T323A TMB high",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 177879,
            "transcript": "XM_011534800",
            "gDna": "chr12:g.132676598G>C",
            "cDna": "c.857C>G",
            "protein": "p.P286R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 177880,
            "transcript": "XM_011534799",
            "gDna": "chr12:g.132676598G>C",
            "cDna": "c.857C>G",
            "protein": "p.P286R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 177878,
            "transcript": "XM_011534795",
            "gDna": "chr12:g.132676598G>C",
            "cDna": "c.857C>G",
            "protein": "p.P286R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 177877,
            "transcript": "NM_006231",
            "gDna": "chr12:g.132676598G>C",
            "cDna": "c.857C>G",
            "protein": "p.P286R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}